Conforta (Beijing) Technology Co., Ltd. officially sets sail! Dedicated to advancing medical nutrition R&D, we are driving progress toward a healthier future

A New Chapter in Health | Conforta (Beijing) Technology Co., Ltd. is Officially Established!

On April 25, 2025, Conforta (Beijing) Technology Co., Ltd. (hereinafter referred to as "Conforta") was officially inaugurated in Beijing. As a medical nutrition research center formed by the strategic collaboration between Conforta FSMP (Zhengzhou) Co., Ltd. and Beijing Shangxiutang Pharmaceutical Technology Co., Ltd., we are committed to the mission of "Precision Nutrition, Healthy Future."

We focus on research in foods for special medical purposes (FSMP), professional sports nutrition, microecology, and Traditional Chinese Medicine (TCM) based medical nutrition, aiming to provide scientific and comprehensive health solutions for the nation.

Two leading innovative enterprises in the pharmaceutical and medical nutrition fields have joined forces. Through this strong collaboration, they will integrate medical, research, and industrial resources to build a cutting-edge, professional CDMSO platform for medical nutrition in China. The core functions of the platform include:*

1. Process Development and Optimization: Providing medical nutrition companies with process design and technical improvements, from laboratory scale-up to large-scale production.

2. Customized Manufacturing: Offering production services ranging from kilogram to ton scale, covering the entire value chain including intermediates, active pharmaceutical ingredients (APIs), and formulations.

3. Technology Empowerment: Leveraging technological advantages to reduce R&D and production costs for medical nutrition companies, and accelerating their commercialization process.

Core Business: Precision Research & Development for Better Health

Technology-Driven Innovation Shapes the Future:
Kangfute brings together a team of top experts from diverse fields such as nutrition, clinical medicine, and food engineering. Collaborating with renowned universities and research institutions in China, we have built an "Industry-Academia-Research" (IAR) collaborative innovation platform, promoting the transformation of scientific research into practical applications and driving industrial upgrading.

Among our core offerings are Foods for Special Medical Purposes (FSMP), specifically developed for special populations such as those with chronic diseases, post-surgical recovery needs, and malnutrition. Our scientifically formulated nutritional products meet national standards and are designed to help patients improve their health and enhance their quality of life.

Four Key Technological Advantages:

• Precision Nutritional Formula Design

• Innovative Application of Functional Ingredients

• Strict Quality and Safety System

• Personalized Nutritional Intervention Programs

Our Vision: Driving Industry Progress and Supporting Healthy China

With the implementation of the "Healthy China 2030" Outline, the fields of preventive science and medical nutrition are poised for explosive growth. Kangfute will take innovation as its driving force to fill market gaps, promote industry standardization, and make science-based nutrition accessible to a broader population.

The future is here — let’s embark on a new journey together!

The establishment of Kangfute (Beijing) Technology Co., Ltd. marks a solid and strategic step forward in Kangfu’s medical nutrition development. Looking ahead, we will continue to deepen our R&D efforts and leverage the power of technology to safeguard the health of the nation, writing a new chapter in the pursuit of better health for all.

*CDMSO: Contract Development, Manufacturing & Sales Organization — an integrated platform for customized R&D, production, and sales.

About Kangfute Medical (Confutmed):

Kangfute Medical Food (Zhengzhou) Co., Ltd. (hereinafter referred to as “Confutmed”) is a Sino-foreign joint venture located in the Central Plains Medical Science City, at the heart of the Zhengzhou Airport Economic Zone. As a key part of Henan Province’s “Three Major Pillars” innovation and technology development plan, the area serves as a strategic base for biomedicine and health industries, an international hub for innovative talents, and a pioneer zone for global medical and health services.

As one of the first companies to establish operations in Zhengzhou specializing in Foods for Special Medical Purposes (FSMP) and medical nutrition products, Confutmed leverages its geographical advantages and the agglomeration effect of the industrial cluster to become a leading enterprise in the domestic FSMP and professional nutrition sector.

Confutmed is dedicated to the research, production, and promotion of special medical foods and sports nutrition products. Its product portfolio spans complete nutritional formulas, disease-specific nutritional formulas, and non-complete nutritional formulas, meeting the nutritional needs of individuals with restricted eating, metabolic disorders, post-surgical recovery, and other special conditions.

With strong policy support and industrial synergy from the Central Plains Medical Science City, Confutmed has established in-depth strategic partnerships with renowned scientific research institutes, Class-3 hospitals, and universities both domestically and internationally. This has enabled the formation of an integrated "Industry-Academia-Research-Clinical Application" innovation system, driving product upgrades and clinical application transformations.

Confutmed envisions itself as a "leader" in the field, focusing on two core directions:

1. Professional Medical Nutrition: Delivering customized nutritional solutions to support healthcare professionals in optimizing patient nutrition interventions across clinical scenarios such as oncology and metabolic diseases.

2. Sports Nutrition Innovation: Developing high-performance nutritional products tailored to the needs of high-intensity training and sports rehabilitation, contributing to improved public health outcomes.

The company plans to expand its product line to include more than 15 medical nutrition products within the next five years, and will build a compliant, full-chain ecosystem covering R&D, production, and distribution through intelligent manufacturing systems and rigorous quality control.

As a representative foreign enterprise in the biomedical industry cluster of the Central Plains Medical Science City, Confutmed actively aligns with the "Healthy China 2030" strategy. By filling domestic technical gaps in FSMP, reducing medical nutrition costs for patients, and promoting high-quality industry development, Confutmed not only fills the gap in Henan’s FSMP industry but also contributes to the global expansion of Chinese FSMP standards and products through international certification and collaboration.

About Shangxiutang:

Beijing Shangxiutang Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Shangxiutang”) is a National High-Tech Enterprise, established in 2007. Located in the Beijing Daxing Biomedical Industry Base — known as China’s "Pharma Valley" — the company has been deeply involved in the pharmaceutical and healthcare industries for 18 years.

As an integrated platform for industry, academia, and research, Shangxiutang has built a core technical team composed of national-level scientific experts. It operates a research center that meets international standards and has established a comprehensive quality management system, forming a dual-driven innovation model combining medicines and functional products.

Shangxiutang’s core advantages include:

1. End-to-End Technical Empowerment Across the Value Chain: Offering full-service solutions from concept design, pharmaceutical research, non-clinical and clinical studies, regulatory registration to final approval.

2. Innovative R&D System: The company has established technical platforms in inhalation formulations, injectables, oral liquids, and controlled/sustained-release drug delivery systems, with multiple invention patents granted.

3. Benchmark Industry Cases: The company serves leading domestic pharmaceutical enterprises such as Sinopharm Group, Shanghai Pharma Group, Glorysky Pharmaceutical, and Health Bay Pharmaceutical, as well as well-known international pharmaceutical brands, successfully completing multiple innovative drug development projects.

4. Quality Control Standards: Full-process digital management ensures data security, traceability, and reliability.

As a practitioner of China’s pharmaceutical industry upgrading, Shangxiutang continues to promote a combination of innovation and imitation, steadily advancing toward its goal of becoming a "leading innovator in China's pharmaceutical product R&D".

Follow Us for More Industry Insights and Product Updates!